Skip to content

THC vs. CBD: What You Need to Know

THC vs. CBD: What You Need to Know

With the rising demand of natural medicines, medical marijuana compounds THC and CBD are starting to make a name for themselves more than ever before. These two compounds have a wide range of health benefits, making it understandable why patients and physicians would be interested in this alternative treatment option. Although these two compounds are derived from the same source and appear to be virtually identical, they affect the human body quite differently.

Cannabinoids and the Endocannabinoid System

Before we dissect these two compounds, it’s important to understand where they come from and what part of the body they affect. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) are just two of the 85 known cannabinoids found in the Cannabis plant.

“A cannabinoid is a compound that interacts directly with our body’s Endocannabinoid System (ECS), which in short, is a network of receptors that interact with cannabinoids to maintain vital functions throughout our body.” (Medium.com/CBD-Origin).

In 1988, scientists discovered the first cannabinoid receptor, with the second coming to light in 1993. In 1995, these two receptors were identified as CB1 and CB2 receptors. “The interaction between the CB1 and CB2 receptors with cannabinoids like CBD and THC is the catalyst for health benefits such as pain relief, anxiety relief, appetite stimulation, mood management and more.”

Molecular Makeup

As far as chemical makeup goes, THC and CBD are the exact same: 21 carbon atoms, 30 hydrogen atoms and two oxygen atoms. Take a look at the figure below. The differentiator between the two compounds is the placement of one single atom through their structure. For reference, one atom is one million times smaller than a human hair, so we’re talking about a microscopic difference.

While a microscopic difference might not seem like a big deal, it’s exactly what makes these two compounds react with our body in surprisingly different ways. These different reactions are due to the fact that THC and CBD have different molecular structures, causing them to have dissimilar interactions with CB1 and CB2.

THC vs. CBD: How Each Affects the Body

Despite their near identical structures, THC and CBD differ when it comes to psychoactive effects. In fact, CBD is a non-psychoactive compound, meaning it doesn’t produce the “high” feeling associated with THC.

Due to its molecular structure, THC is able to bind strongly with CB1 receptors. When this bond is formed, the reaction creates signals that are then sent to the brain. These reactions are the core source of the well-known psychoactive response of “getting high”.

On the complete opposite side of the spectrum, CBD does not bond strongly with CB1 receptors and can even negate the bond between THC and the CB1 receptors. By doing this, those psychoactive effects induced by THC are completely neutralized.

“While THC certainly offers tremendous health benefits, its mind-altering effects aren’t preferred by everyone. CBD, on the other hand, can deliver many of the same benefits of THC without inducing its psychoactive effects. Plus, when using CBD vs THC, you typically won’t be breaking the law.” (Medium.com/CBD-Origin)

Are YOU ready to put CBD and THC to the test with your patients? Join Arfinn Med for FREE to get real medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings.

Looking for more information about CBD and THC? Check out these two articles to learn more about the health benefits and side effects:

https://medium.com/cbd-origin/cbd-vs-thc-the-difference-explained-b3cfc1da52f0

https://www.healthline.com/health/cbd-vs-thc#psychoactive-components

Stories you may be interested in

Medical marijuana advocates concerned over recreational cannabis proposals

ALBUQUERQUE, N.M.— Some medical marijuana patients are concerned the proposed framework for legalizing recreational marijuana could have a potentially negative impact on the medical cannabis program. “It’s something that will devastate the medical program in doing so,” said Jason Barker, a medical cannabis advocate with Safe Access New Mexico. A special task force delivered a…
Read More

Minnesota study finds that medical pot soothes cancer pains

Symptoms such as pain and nausea improved in cancer patients who took cannabis, according to new research that is part of Minnesota’s effort to address the information void about whether marijuana offers medical benefits. Analyzing 1,120 cancer patients who received cannabis through the state medical marijuana program, researchers reported Monday that they found noteworthy improvements…
Read More

LEGALIZING CANNABIS LINKED TO LESS OPIOID PRESCRIPTIONS, COULD HELP COMBAT EPIDEMIC, SCIENTISTS SAY

There are less opioid prescriptions on average in U.S. states where medical and recreational marijuana are legal, research has revealed. Access to recreational cannabis in the U.S. was tied with a 11.8 percent lower rate of opioids prescriptions each day, and 4.2 percent for medical marijuana. The authors of the paper published in the Journal of Health Economics said recreational weed…
Read More

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

New Feature Updates

It’s a new feature alert! At Arfinn Med we always work to make sure we are the industry leading software platform and EMR for medical cannabis providers and clinics. Keeping with that sentiment, we’ve recently updated two features that have been very popular with Arfinn Med users.  Those are the customizable consent and confirmation page…
Read More

Leave a Comment

You must be logged in to post a comment.